Deploy a Chief Executive Officer for your biotech or pharma company.
Bypass bloated consulting firms. Secure a US-based, Ivy League-educated CEO to navigate crossover or series c fundraise — entirely remotely, deployed in 48 hours.
What Biotech & Pharma CEOs hire CEOs to solve.
- 01Capital efficiency between trial milestones
- 02Clinical, regulatory and commercial coordination
- 03BD, licensing and pharma-partner negotiations
- 04GxP, quality and supply chain readiness
Where this CEO plugs in across Biotech & Pharma.
Founder stepping back from day-to-day operations
PE-backed portfolio company post-acquisition stabilization
Pre-Series B startup preparing for institutional raise
Family business navigating generational transition
What lands in week one.
- →90-day turnaround plan with stage-gated milestones
- →Investor pitch deck, data room, and narrative arc
- →Board operating cadence, charter, and reporting pack
- →Executive scorecard and accountability framework
The scoreboard they answer to.
- ·Cash runway extension (months)
- ·Board NPS and investor confidence index
- ·Executive team retention and quota attainment
- ·Top-line growth and gross margin expansion
A Crimson Bench CEO stabilizes the executive room, converts ambiguity into board-grade decisions, and gives investors a single accountable operator for strategy, capital, people, and execution cadence.
Six tiers. One bench. Zero hidden fees.
Every tier deploys your CEO — same operator, scaled to the depth of mandate your biotech or pharma company needs.
Intensive corporate audit. Client submits raw P&L or operational overview; executive delivers a 3-page triage roadmap.
Two 90-minute advisory calls per month with asynchronous email and Slack access for high-level decision support.
Dedicated C-suite oversight. Executive owns KPI tracking, manages team meetings, and drives weekly execution.
Deep operational execution. Best for rapid scaling phases, pre-funding rounds, or intensive systemic cleanups.
Full-time (4–5 days/week) coverage during acute crises, sudden executive departures, or active global executive searches.
Physical placement at corporate HQ, manufacturing facilities, or boardrooms. Calculated on location, travel, lodging, and complexity.